Article Details

Targeting MDM2 Enhances Antileukemia Immunity After Allogeneic Transplantation

Retrieved on: 2022-10-10 10:46:17

Tags for this article:

Click the tags to see associated articles and topics

Targeting MDM2 Enhances Antileukemia Immunity After Allogeneic Transplantation. View article details on hiswai:

Excerpt

Researchers found that blocking mouse-double-minute-2 (MDM2) prevented AML from evading the immune system in a study.

Article found on: www.physiciansweekly.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up